* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAVQISKKR ------CCCCCCCCC | 11.26 | - | |
6 | Phosphorylation | --MAVQISKKRKFVA --CCCCCCCCCCCCC | 18.29 | - | |
10 | Ubiquitination | VQISKKRKFVADGIF CCCCCCCCCCCCCCH | 53.74 | - | |
10 | Acetylation | VQISKKRKFVADGIF CCCCCCCCCCCCCCH | 53.74 | 22826441 | |
18 | Ubiquitination | FVADGIFKAELNEFL CCCCCCHHHHHHHHH | 38.74 | - | |
18 | Acetylation | FVADGIFKAELNEFL CCCCCCHHHHHHHHH | 38.74 | 22826441 | |
35 | Phosphorylation | ELAEDGYSGVEVRVT HHHHCCCCCEEEEEC | 41.72 | 28066266 | |
42 | Phosphorylation | SGVEVRVTPTRTEII CCEEEEECCCCCEEE | 14.37 | - | |
62 | Acetylation | TQNVLGEKGRRIREL CCCCCCCHHHHHHHH | 56.79 | 23806337 | |
62 | Ubiquitination | TQNVLGEKGRRIREL CCCCCCCHHHHHHHH | 56.79 | - | |
62 | Malonylation | TQNVLGEKGRRIREL CCCCCCCHHHHHHHH | 56.79 | 26320211 | |
64 | Asymmetric dimethylarginine | NVLGEKGRRIRELTA CCCCCHHHHHHHHHH | 41.75 | - | |
64 | Methylation | NVLGEKGRRIRELTA CCCCCHHHHHHHHHH | 41.75 | - | |
65 | Methylation | VLGEKGRRIRELTAV CCCCHHHHHHHHHHH | 40.77 | - | |
65 | Asymmetric dimethylarginine | VLGEKGRRIRELTAV CCCCHHHHHHHHHHH | 40.77 | - | |
67 | Methylation | GEKGRRIRELTAVVQ CCHHHHHHHHHHHHH | 30.94 | - | |
67 | Asymmetric dimethylarginine | GEKGRRIRELTAVVQ CCHHHHHHHHHHHHH | 30.94 | - | |
70 | Phosphorylation | GRRIRELTAVVQKRF HHHHHHHHHHHHHHH | 16.80 | 18779572 | |
75 | Acetylation | ELTAVVQKRFGFPEG HHHHHHHHHHCCCCC | 37.78 | 22826441 | |
75 | Ubiquitination | ELTAVVQKRFGFPEG HHHHHHHHHHCCCCC | 37.78 | 22790023 | |
87 | Phosphorylation | PEGSVELYAEKVATR CCCCCHHHHHHHHHH | 10.14 | 25367039 | |
90 | Malonylation | SVELYAEKVATRGLC CCHHHHHHHHHHHHH | 29.06 | 26073543 | |
90 | Ubiquitination | SVELYAEKVATRGLC CCHHHHHHHHHHHHH | 29.06 | - | |
90 | Acetylation | SVELYAEKVATRGLC CCHHHHHHHHHHHHH | 29.06 | 23236377 | |
97 | S-palmitoylation | KVATRGLCAIAQAES HHHHHHHHHHHCHHH | 2.61 | 28526873 | |
97 | Glutathionylation | KVATRGLCAIAQAES HHHHHHHHHHHCHHH | 2.61 | 24333276 | |
97 | S-nitrosylation | KVATRGLCAIAQAES HHHHHHHHHHHCHHH | 2.61 | 24926564 | |
97 | S-nitrosocysteine | KVATRGLCAIAQAES HHHHHHHHHHHCHHH | 2.61 | - | |
104 | Phosphorylation | CAIAQAESLRYKLLG HHHHCHHHHHHHHHH | 22.59 | 26745281 | |
107 | Phosphorylation | AQAESLRYKLLGGLA HCHHHHHHHHHHHHH | 15.98 | 23984901 | |
108 | Ubiquitination | QAESLRYKLLGGLAV CHHHHHHHHHHHHHH | 30.70 | - | |
108 | Malonylation | QAESLRYKLLGGLAV CHHHHHHHHHHHHHH | 30.70 | 26320211 | |
108 | Acetylation | QAESLRYKLLGGLAV CHHHHHHHHHHHHHH | 30.70 | 23806337 | |
119 | Glutathionylation | GLAVRRACYGVLRFI HHHHHHHHHHHHHHH | 2.63 | 24333276 | |
119 | S-nitrosylation | GLAVRRACYGVLRFI HHHHHHHHHHHHHHH | 2.63 | 21278135 | |
119 | S-palmitoylation | GLAVRRACYGVLRFI HHHHHHHHHHHHHHH | 2.63 | 26165157 | |
119 | S-nitrosocysteine | GLAVRRACYGVLRFI HHHHHHHHHHHHHHH | 2.63 | - | |
120 | Phosphorylation | LAVRRACYGVLRFIM HHHHHHHHHHHHHHH | 14.86 | 25367039 | |
132 | Succinylation | FIMESGAKGCEVVVS HHHHCCCCCCEEEEC | 68.56 | 23806337 | |
132 | Succinylation | FIMESGAKGCEVVVS HHHHCCCCCCEEEEC | 68.56 | - | |
132 | Acetylation | FIMESGAKGCEVVVS HHHHCCCCCCEEEEC | 68.56 | 23806337 | |
132 | Malonylation | FIMESGAKGCEVVVS HHHHCCCCCCEEEEC | 68.56 | 26320211 | |
134 | Glutathionylation | MESGAKGCEVVVSGK HHCCCCCCEEEECCC | 3.37 | 24333276 | |
134 | S-nitrosocysteine | MESGAKGCEVVVSGK HHCCCCCCEEEECCC | 3.37 | - | |
134 | S-nitrosylation | MESGAKGCEVVVSGK HHCCCCCCEEEECCC | 3.37 | 24926564 | |
139 | Phosphorylation | KGCEVVVSGKLRGQR CCCEEEECCCCCCCC | 20.71 | 25293948 | |
141 | Acetylation | CEVVVSGKLRGQRAK CEEEECCCCCCCCCC | 27.75 | 22826441 | |
141 | Ubiquitination | CEVVVSGKLRGQRAK CEEEECCCCCCCCCC | 27.75 | - | |
166 | Phosphorylation | HSGDPVNYYVDTAVR ECCCCCHHHHHHHHH | 12.71 | - | |
187 | Acetylation | GVLGIKVKIMLPWDP CCCEEEEEEEECCCC | 19.86 | 22826441 | |
197 | Malonylation | LPWDPSGKIGPKKPL ECCCCCCCCCCCCCC | 49.15 | 26320211 | |
197 | Acetylation | LPWDPSGKIGPKKPL ECCCCCCCCCCCCCC | 49.15 | 23201123 | |
197 | Ubiquitination | LPWDPSGKIGPKKPL ECCCCCCCCCCCCCC | 49.15 | - | |
201 | Malonylation | PSGKIGPKKPLPDHV CCCCCCCCCCCCCCE | 62.91 | 26320211 | |
201 | Phosphoglycerylation | PSGKIGPKKPLPDHV CCCCCCCCCCCCCCE | 62.91 | - | |
201 | Ubiquitination | PSGKIGPKKPLPDHV CCCCCCCCCCCCCCE | 62.91 | - | |
202 | Malonylation | SGKIGPKKPLPDHVS CCCCCCCCCCCCCEE | 55.72 | 26320211 | |
202 | Ubiquitination | SGKIGPKKPLPDHVS CCCCCCCCCCCCCEE | 55.72 | - | |
209 | Phosphorylation | KPLPDHVSIVEPKDE CCCCCCEEECCCCCC | 19.93 | 24925903 | |
214 | Acetylation | HVSIVEPKDEILPTT CEEECCCCCCCCCCC | 55.26 | 23954790 | |
214 | Ubiquitination | HVSIVEPKDEILPTT CEEECCCCCCCCCCC | 55.26 | 22790023 | |
220 | Phosphorylation | PKDEILPTTPISEQK CCCCCCCCCCCCCCC | 41.58 | 24925903 | |
221 | Phosphorylation | KDEILPTTPISEQKG CCCCCCCCCCCCCCC | 19.38 | 27087446 | |
224 | Phosphorylation | ILPTTPISEQKGGKP CCCCCCCCCCCCCCC | 34.87 | 24925903 | |
227 | Ubiquitination | TTPISEQKGGKPEPP CCCCCCCCCCCCCCC | 66.63 | - | |
230 | Malonylation | ISEQKGGKPEPPAMP CCCCCCCCCCCCCCC | 55.68 | 26320211 | |
230 | Ubiquitination | ISEQKGGKPEPPAMP CCCCCCCCCCCCCCC | 55.68 | - | |
242 | Phosphorylation | AMPQPVPTA------ CCCCCCCCC------ | 45.28 | 23684622 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
6 | S | Phosphorylation | Kinase | PRKCD | P28867 | Uniprot |
42 | T | Phosphorylation | Kinase | MAPK | - | Uniprot |
70 | T | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
70 | T | Phosphorylation | Kinase | PKB | P31750 | Uniprot |
209 | S | Phosphorylation | Kinase | IKKB | O88351 | Uniprot |
221 | T | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
18 | K | Sumoylation |
| - |
209 | S | Phosphorylation |
| - |
214 | K | Sumoylation |
| - |
214 | K | ubiquitylation |
| - |
221 | T | Phosphorylation |
| 17242355 |
230 | K | Sumoylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RS3_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations."; Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.; Mol. Cell. Proteomics 6:283-293(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-221, AND MASSSPECTROMETRY. | |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-221, AND MASSSPECTROMETRY. |